BIRC8 and chronic myelogenous leukemia, BCR-ABL1 positive: When the expression of ILP-2 was detected patients with chronic myeloid leukemia (CML), it was found that the expression of ILP-2 was significantly higher in CML patients than in normal hematopoietic cells.